Article 1: MOLECULAR SYNOPSIS Article 2 (will follow with Clinical Trial Results) Walk into the “Sweet-Café” and you are greeted by a plethoric menu of anti-diabetic drugs aimed at reducing your sugar! And now, menu contains another completely new innovation of the anti-sugar brigade viz.
A New molecule, Imeglimin is a New class (Glimin), with a New mechanistic bouquet (mitochondrial bioenergetics leading to multiple glucose-reducing effects) … with great promise of New applications too beyond T2DM. Name of Molecule : IMEGLIMIN Chemical Category : TETRAHYDROTRIAZENE Mechanism of Action: amongst the known mechanisms in the mitochondria are 3 listed : (a) Increased Mitochondrial oxidation of lipids (b) Protection from oxidative stress by the reduction in ROS overproduction (c) Increase in mitochondrial biogenesis (numbers) by upregulating PGC1a Effects on Blood Glucose: is an …
